Voyager’s Gene Therapy Improves Parkinson’s Patients’ Movement Over Long Term, Trial Shows – Parkinson’s News Today
Parkinson’s News Today |
Voyager's Gene Therapy Improves Parkinson's Patients' Movement Over Long Term, Trial Shows
Parkinson’s News Today A single administration of Voyager Therapeutics gene therapy improves advanced Parkinson's patients' movement up to three years later, a Phase 1b trial indicates. Voyager designed VY-AADC01 to deliver the aromatic L-amino acid decarboxylase (AADC) gene … |
